Exelixis reported $627M in Cash and Equivalent for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Acadia Pharmaceuticals ACAD:US $ 139.83M 65.09M
Agios Pharmaceuticals AGIO:US $ 88.54M 8.52M
Akebia Therapeutics AKBA:US $ 143.89M 30.67M
Amgen AMGN:US $ 5203M 1325M
AstraZeneca AZN:LN 395649.11M 43092.62M
Bayer BAYN:GR € 3412M 2373M
Biomarin Pharmaceutical BMRN:US $ 619.8M 14.36M
Bluebird Bio BLUE:US $ 81.5M 24.76M
Bristol Myers Squibb BMY:US $ 10750M 1619M
Cytokinetics CYTK:US $ 93.63M 21.79M
Eisai 4523:JP Y 287815M 23426M
Eli Lilly And LLY:US $ 2622.9M 163.7M
Esperion Therapeutics ESPR:US $ 122.94M 27.42M
Exelixis EXEL:US $ 627M 96.27M
Genmab GEN:DC DK 9816M 745M
Glaxosmithkline GSK:US $ 6465M 4502M
Immunogen IMGN:US $ 373.87M 63.79M
IONIS PHARMACEUT IONS:US $ 521.92M 20.6M
Macrogenics MGNX:US $ 21.47M 25.86M
Mirati Therapeutics MRTX:US $ 245.51M 47.91M
Moderna Inc MRNA:US 2.87B 2.18B
Nektar Therapeutics NKTR:US $ 77.54M 9.55M
Neurocrine Biosciences NBIX:US $ 163.3M 106.9M
Novartis NOVN:VX SF 3625M 10227M
Puma Biotechnology PBYI:US $ 52.76M 11.16M
Seattle Genetics SGEN:US $ 364.87M 103.88M
Takeda 4502:JP Y 645991M 203704M
Ultragenyx Pharmaceutical RARE:US $ 159.87M 5.88M
Xencor XNCR:US $ 49.41M 28.86M
YTE INCY:US $ 2435.38M 178.62M